In light of recent evidence implicating PTC-introducing exons in lung cancer disease-free survival (Thomas et al., 2020), we sought to investigate whether the subset of FOXA1-regulated NMD-determinant exons could impact PC patient prognosis. This evidence concerns the gene FOXA1 and lung carcinoma.